Methylprednisolone fails to preserve retinal ganglion cells and visual function after ocular ischemia in rats
- PMID: 18586870
- DOI: 10.1167/iovs.08-1869
Methylprednisolone fails to preserve retinal ganglion cells and visual function after ocular ischemia in rats
Abstract
Purpose: Methylprednisolone (MP) is commonly used to treat traumatic optic neuropathy and optic neuritis, but its benefit in terms of neuronal survival remains controversial. The aim of this study was to investigate the effects of MP on retinal ganglion cell (RGC) survival and visual function after ischemia in rats.
Methods: Ocular ischemia was induced by elevated intraocular pressure. Rats were treated with NaCl, 1 mg/kg/d, or 30 mg/kg/d intraperitoneal MP over 3 days. RGCs were labeled retrogradely 4 days after ischemia and were quantified 6 days later. Post-ischemic retinal function was assessed by scotopic and photopic electroretinography (ERG). Optic nerve function was investigated on days 4 and 10 after ischemia by visual evoked potentials (VEPs).
Results: Compared with nonischemic eyes, ischemia reduced RGCs with NaCl to 47% +/- 3% (mean +/- SEM) and to 46% +/- 3% and 43% +/- 6% with 1 mg/kg/d and 30 mg/kg/d MP. ERG did not differ significantly for any parameter among the three groups. Four days after ischemia, the VEPs of rats receiving any dose of MP were significantly higher than the control. VEPs in both steroid groups fell to control levels 10 days after ischemia.
Conclusions: Treatment with MP did not improve RGC survival or retinal function. The VEP showed a short-term benefit because of steroids.
Similar articles
-
Quantification of ischemic damage in the rat retina: a comparative study using evoked potentials, electroretinography, and histology.Invest Ophthalmol Vis Sci. 2008 Mar;49(3):1056-64. doi: 10.1167/iovs.07-1050. Invest Ophthalmol Vis Sci. 2008. PMID: 18326730
-
Neuroprotective effects of brimonidine against transient ischemia-induced retinal ganglion cell death: a dose response in vivo study.Exp Eye Res. 2002 Feb;74(2):181-9. doi: 10.1006/exer.2001.1122. Exp Eye Res. 2002. PMID: 11950228
-
Statins modulate heat shock protein expression and enhance retinal ganglion cell survival after transient retinal ischemia/reperfusion in vivo.Invest Ophthalmol Vis Sci. 2008 Nov;49(11):4971-81. doi: 10.1167/iovs.07-1597. Epub 2008 Jun 19. Invest Ophthalmol Vis Sci. 2008. PMID: 18566458
-
Optic neuropathies: characteristic features and mechanisms of retinal ganglion cell loss.Rev Neurosci. 2013;24(3):301-21. doi: 10.1515/revneuro-2013-0003. Rev Neurosci. 2013. PMID: 23612594 Review.
-
[Electrophysiology in optic neuropathy].Wiad Lek. 2004;57(5-6):271-4. Wiad Lek. 2004. PMID: 15518075 Review. Polish.
Cited by
-
Toxoplasma gondii infection in the peritoneal macrophages of rats treated with glucocorticoids.Parasitol Res. 2014 Jan;113(1):351-8. doi: 10.1007/s00436-013-3661-3. Epub 2013 Nov 19. Parasitol Res. 2014. PMID: 24248630
-
Anti-vascular endothelial growth factor drugs combined with laser photocoagulation maintain retinal ganglion cell integrity in patients with diabetic macular edema: study protocol for a prospective, non-randomized, controlled clinical trial.Neural Regen Res. 2024 Apr;19(4):923-928. doi: 10.4103/1673-5374.382104. Neural Regen Res. 2024. PMID: 37843230 Free PMC article.
-
Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) are more susceptible to retinal ischemic injury in vivo.Neurotox Res. 2012 Jan;21(1):41-8. doi: 10.1007/s12640-011-9254-y. Epub 2011 Jun 30. Neurotox Res. 2012. PMID: 21717232
-
Current options for the treatment of optic neuritis.Clin Ophthalmol. 2012;6:1211-23. doi: 10.2147/OPTH.S28112. Epub 2012 Jul 31. Clin Ophthalmol. 2012. PMID: 22927730 Free PMC article.
-
The Diagnosis and Treatment of Optic Neuritis.Dtsch Arztebl Int. 2015 Sep 11;112(37):616-25; quiz 626. doi: 10.3238/arztebl.2015.0616. Dtsch Arztebl Int. 2015. PMID: 26396053 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
